Anbio Biotechnology (NNNN) Assets Average (2024 - 2025)
Anbio Biotechnology's (NNNN) quarterly Assets Average came in at $13840.3 billion in Q4 2025, up 79694093.8% year-on-year from N/an in Q4 2024, and little changed on a QoQ basis from $13840.3 billion in Q2 2025.
Anbio Biotechnology (NNNN) Assets Average (2024 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has 2 years of Assets Average data on file, last reported at $13840.3 billion in Q4 2025.
- On a quarterly basis, Assets Average rose 79694093.8% year-over-year to $13840.3 billion in Q4 2025; TTM through Dec 2025 was $13840.3 billion, a 79694093.8% increase from a year earlier, with the FY2025 full-year figure at $24.6 million, up 41.55% from the prior year.
- Assets Average for Q4 2025 stood at $13840.3 billion, roughly flat from $13840.3 billion in the prior quarter.
- Over the last five years, Assets Average for NNNN reached as high as $13840.3 billion in Q4 2025 and fell as low as $17.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.59 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 52.84 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 38.75 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.64 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.09 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.45 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.20 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.27 Bn |
| 10 | Anbio Biotechnology | 425.37 Mn | 413.46 Mn | - | 13,840.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,840.31 Bn |
| Jun 30, 2025 | 13,840.31 Bn |
| Dec 31, 2024 | 17.37 Mn |